latest news in Pharmaceutical Tariffs

Bristol Myers Squibb Secures Tariff Exemption via Medicaid Access Deal

Bristol Myers Squibb Secures Tariff Exemption via Medicaid Access Deal

Princeton, Saturday, 20 December 2025.
In a strategic trade-off with the Trump administration, Bristol Myers Squibb secures a three-year tariff exemption by providing Eliquis free to Medicaid and donating seven tons of active pharmaceutical ingredients.